Expression of MCT4 and combined LDH (LDHA and LDHB) in the tumour epithelium are important in determining clinically significant intermediate-risk disease, while MCT1 expression may also play a role in more aggressive tumours. The gene discussed is SLC16A3; the disease is neoplasm.